What's new

Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 49, Status: Authorised

Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 49, Status: Authorised

Apr 11, 2025 - 16:34
 0
Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 49, Status: Authorised
Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 49, Status: Authorised
Read More

Tags:

Previous Article

Smart Tips For Diesel Maintenance That'll Keep Your Engine Running

Next Article

Trump’s offshore wind policies limit industry’s near-term growth: Morningstar DB...

Related Posts

EMEA-002727-PIP02-23

EMEA-002727-PIP02-23

Mar 4, 2025  0

PSUSA/00010199/202405

PSUSA/00010199/202405

Mar 7, 2025  0

Orphan designation: zopapogene imadenovec Treatment of recurrent respiratory papillomatosis, 12/01/2024 Positive

Orphan designation: zopapogene imadenovec Treatment of ...

Feb 20, 2025  0